Vanguard Portfolio Management’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
GJL
Vanguard Portfolio Management's CLB Position: Q3 2026 in Review
Vanguard Portfolio Management reduced its Core Laboratories (CLB) stake by 41% in Q3 2026, selling an estimated $6.02M and leaving 755,589 shares worth $7.33M. The position accounts for ﹤0.01% of the portfolio, ranked #2265.
Vanguard Portfolio Management first reported a position in CLB in Q1 2026 and has held it in 3 quarters since. The position peaked at $21.1M in Q1 2026. 180 funds tracked by Wall St. Rank hold CLB as of Q3 2026.
- Vanguard Portfolio Management held 755,589 shares of Core Laboratories worth $7.33M as of Q3 2026.
- Vanguard Portfolio Management sold 519,832 Core Laboratories shares in Q3 2026, an estimated $6.02M.
- Core Laboratories made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q3 2026, its #2265 holding.
- Vanguard Portfolio Management first reported a position in Core Laboratories in Q1 2026 and has held it in 3 quarters since.
- Vanguard Portfolio Management's Core Laboratories position peaked at $21.1M in Q1 2026.
- 180 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2026.
Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.